EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population

Bennett A McIver iD, Tara S Davis iD, Kimberly Reinhart, Elizabeth Vera, Alvina Acquaye-Mallory iD, Anna Choi, Tricia Kunst, Morgan Johnson, Ewa Grajkowska, Hope Miller, Jennifer Reyes, Mark R Gilbert und 2 weitere

Cancer Medicine · 2025-03 · 14 (5)

DOI: 10.1002/cam4.70682 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cancer Medicine, online erschienen am 07.03.2025. Verfasst von Bennett A McIver und 13 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Activities of Daily Living, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Symptom burden associated with interference in daily functioning is worse in those with progression or higher‐grade glial tumors. This exploratory study aims to identify factors associated with its severity in a diverse cross‐sectional cohort of 566 brain tumor patients enrolled in a natural history study (NCT03251989, PI: T.S. Armstrong).

Methods

Sociodemographic and clinical data and self‐reported activity‐related interference (work, general activity, walking), mood‐related interference (relations with others, enjoyment of life, mood) were reported via the MD Anderson Symptom Inventory‐Brain Tumor. Activity and mood‐related interference mean scores ≥ 2 were categorized as moderate–severe. Logistic regression assessed univariate associations with moderate–severe interference. Characteristics significant in the univariate analysis were included in a multivariable analysis.

Results

This patient sample had a median age of 48 years (18–85), was mostly male (57%), with a high‐grade tumor (73%), glioblastoma (39%), and tumor recurrence (49%). Risk factors for moderate–severe activity‐related interference included: ≥ 2 surgeries (OR = 1.64, 95% CI [1.10, 2.44], p = 0.015), ependymoma (OR = 2.59, 95% CI [1.21–5.53], p = 0.014), and childhood in a rural area (OR = 1.74, 95% CI [1.15–2.63] p = 0.009). Risk factors for moderate–severe mood‐related interference included tumor progression (OR = 2.02, 95% CI [1.21–3.36], p = 0.009).

Conclusion

Patient reported interference with daily physical functioning is associated with sociodemographic and disease‐related characteristics and notably worse mood‐related interference in those with progression. Future studies should include social determinants of health and change over time to identify and plan interventions for those at risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activities of Daily LivingBrain NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultCost of IllnessCross-Sectional StudiesQuality of LifeRisk FactorsSociodemographic FactorsSymptom Burden

Stichwörter der Autor:innen

activity‐related interferencefunctional interferencemood‐related interferenceprimary brain tumors

Autor:innen und Institutionen

  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Bennett A McIver, Tara S Davis, Alvina Acquaye-Mallory, Michelle L Wright

Förderung

  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

McIver, B. A., Davis, T. S., Reinhart, K., Vera, E., Acquaye-Mallory, A., Choi, A., Kunst, T., Johnson, M., Grajkowska, E., Miller, H., Reyes, J., Gilbert, M. R., Armstrong, T. S., & Wright, M. L. (2025). Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population. Cancer Medicine, 14(5). https://doi.org/10.1002/cam4.70682

Vancouver

McIver BA, Davis TS, Reinhart K, Vera E, Acquaye-Mallory A, Choi A, et al. Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population. Cancer Medicine. 2025;14(5). doi:10.1002/cam4.70682

BibTeX
@article{McIver2025,
  author = {McIver, Bennett A and Davis, Tara S and Reinhart, Kimberly and Vera, Elizabeth and Acquaye-Mallory, Alvina and Choi, Anna and Kunst, Tricia and Johnson, Morgan and Grajkowska, Ewa and Miller, Hope and Reyes, Jennifer and Gilbert, Mark R and Armstrong, Terri S and Wright, Michelle L},
  title = {Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {5},
  doi = {10.1002/cam4.70682}
}
Kostenlos starten →